Top

Published in:

01-12-2021 | Coronavirus | Viewpoint

COVID-19: What we’ve done well and what we could or should have done better—the 4 Ps

Authors: Jean-Louis Vincent, Julia Wendon, Greg S. Martin, Nicole P. Juffermans, Jacques Creteur, Maurizio Cecconi

Published in: Critical Care | Issue 1/2021

Abstract

The current coronavirus pandemic has impacted heavily on ICUs worldwide. Although many hospitals and healthcare systems had plans in place to manage multiple casualties as a result of major natural disasters or accidents, there was insufficient preparation for the sudden, massive influx of severely ill patients with COVID-19. As a result, systems and staff were placed under immense pressure as everyone tried to optimize patient management. As the pandemic continues, we must apply what we have learned about our response, both good and bad, to improve organization and thus patient care in the future.

Grasselli G, Pesenti A, Cecconi M. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. JAMA. 2020;323:1545–6.CrossRef

ESICM. C19_Space Skills Preparation Course. https://www.esicm.org/wp-content/uploads/2020/10/C19_SPACE-2020.pdf. Accessed 29/12/20

SCCM. Critical care for non-ICU clinicians. https://sccm.org/Disaster/COVID19-ResourceResponseCenter. Accessed 29/12/20

Pons S, Fodil S, Azoulay E, Zafrani L. The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection. Crit Care. 2020;24:353.CrossRef

Remmelink M, De Mendonca R, D’Haene N, De Clercq S, Verocq C, Lebrun L, et al. Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients. Crit Care. 2020;24:495.CrossRef

Dennis JM, McGovern AP, Vollmer SJ, Mateen BA. Improving survival of critical care patients with Coronavirus Disease 2019 in England: a national cohort study, March to June 2020. Crit Care Med. 2021;49:209–14.CrossRef

Pan H, Peto R, Henao-Restrepo AM, Preziosi MP, Sathiamoorthy V, Abdool Karim Q, et al. Repurposed antiviral drugs for COVID-19-interim WHO SOLIDARITY trial results. N Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2023184.CrossRefPubMedPubMedCentral

Burki TK. Completion of clinical trials in light of COVID-19. Lancet Respir Med. 2020;8:1178–80.CrossRef

Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, et al. Dexamethasone in hospitalized patients with Covid-19—preliminary report. N Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2021436.CrossRefPubMedPubMedCentral

10.

De Backer D, Azoulay E, Vincent JL. Corticosteroids in severe COVID-19: a critical view of the evidence. Crit Care. 2020;24:627.CrossRef

11.

Vincent JL, Francois B, Zabolotskikh I, Daga MK, Lascarrou JB, Kirov MY, et al. Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: the SCARLET Randomized Clinical Trial. JAMA. 2019;321:1993–2002.CrossRef

12.

Pairo-Castineira E, Clohisey S, Klaric L, Bretherick AD, Rawlik K, Pasko D, et al. Genetic mechanisms of critical illness in Covid-19. Nature. 2020. https://doi.org/10.1038/s41586-020-03065-y.CrossRefPubMed

13.

Gattinoni L, Chiumello D, Rossi S. COVID-19 pneumonia: ARDS or not? Crit Care. 2020;24:154.CrossRef

14.

Shrestha GS, Paneru HR, Vincent JL. Precision medicine for COVID-19: a call for better clinical trials. Crit Care. 2020;24:282.CrossRef

15.

Leisman DE, Ronner L, Pinotti R, Taylor MD, Sinha P, Calfee CS, et al. Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes. Lancet Respir Med. 2020;8:1233–44.CrossRef

16.

Aziz S, Arabi YM, Alhazzani W, Evans L, Citerio G, Fischkoff K, et al. Managing ICU surge during the COVID-19 crisis: rapid guidelines. Intensive Care Med. 2020;46:1303–25.CrossRef

17.

Emanuel EJ, Persad G, Upshur R, Thome B, Parker M, Glickman A, et al. Fair allocation of scarce medical resources in the time of Covid-19. N Engl J Med. 2020;382:2049–55.CrossRef

18.

Vincent JL, Creteur J. Ethical aspects of the COVID-19 crisis: How to deal with an overwhelming shortage of acute beds. Eur Heart J Acute Cardiovasc Care. 2020;9:248–52.CrossRef

19.

White DB, Lo B. A framework for rationing ventilators and critical care beds during the COVID-19 pandemic. JAMA. 2020;323:1773–4.CrossRef

20.

White DB, Angus DC. A proposed lottery system to allocate scarce COVID-19 medications: promoting fairness and generating knowledge. J A M A. 2020;324:329–30.CrossRef

Title: COVID-19: What we’ve done well and what we could or should have done better—the 4 Ps
Authors: Jean-Louis Vincent
Julia Wendon
Greg S. Martin
Nicole P. Juffermans
Jacques Creteur
Maurizio Cecconi
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: Coronavirus
COVID-19
Published in: Critical Care / Issue 1/2021
Electronic ISSN: 1364-8535
DOI: https://doi.org/10.1186/s13054-021-03467-y

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

COVID-19: What we’ve done well and what we could or should have done better—the 4 Ps

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2021

Knowledge translation tools to guide care of non-intubated patients with acute respiratory illness during the COVID-19 Pandemic

Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study

Clearance of inflammatory cytokines in patients with septic acute kidney injury during renal replacement therapy using the EMiC2 filter (Clic-AKI study)

Prolonged time from intubation to cannulation in VV-ECMO for COVID-19: does it really matter?

Anti-Xa activity and hemorrhagic event: isn’t it time to consider time ?

Restricted visitation policies in acute care settings during the COVID-19 pandemic: a scoping review